The Vitals

Wyden Introduces Drug Price Transparency Bill Targeting Drug Companies

June 13, 2017
Senate Finance Committee ranking Democrat Ron Wyden introduced Tuesday (June 13) legislation to require that drug makers justify price hikes to the public after the Oregon senator introduced in March a separate bill to make pharmacy benefit managers disclose rebates. Wyden on Tuesday also reintroduced the RxCAP Act, which would cap seniors’ out-of-pocket costs in Medicare Part D. With the three bills, Wyden takes to task the three major players in the drug price debate: drug makers that set prices,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.